With great pleasure, we invite you to the Annual Scientific Meeting of the Netherlands Centre for One Health (NCOH) that takes place on Monday, June 19th, at Corpus in Leiden.
The meeting is aimed at researchers from our Partners and Associates that are involved in all the NCOH Strategic Research Themes. We particularly encourage young researchers (PhD students, postdocs) to join this meeting. This is an exclusive invitation only event. The event is free of charge but registration is required via the email that you have received in your email box. If you would like to attend, but did not receive an invitation please contact us via [email protected].
Please find the detailed programme here.
In the plenary morning session we will host two keynote lectures by prof. Ab Osterhaus and prof. Hans Heesterbeek. In the afternoon, there will be two thematic parallel sessions where various research projects will be highlighted. This will be followed by a networking event where we aim to stimulate collaborations between the NCOH themes.
We hope to meet you at the symposium.
In the second round of the programme Antibiotic Resistence 57 project ideas were submitted. These projects will contribute to the prevention of reduction of antibiotic resistence, with the ‘OneHealth’ approach and behavioural changes as possible perspectives for research.More
On 9 March 2017, Wageningen University & Research celebrated its 99th Dies Natalis with the theme 'Towards a global one health'.More
NACTAR stands for Novel Antibacterial Compounds and Therapies Antagonizing Resistance. This research programme on the development of new antibiotics and alternatives is commissioned by the Dutch Ministry of Health, Welfare and Sport and NWO-domain TTW and connects to the National Antibiotic Development Platform (NADP).More
On 18 April 2017, the Netherlands Antibiotic Development Platform (NADP) was launched in Utrecht with the project partner, and representatives from science, industry, and government. The aim of the launch event was to show how NADP can help facilitate the next step from academic discovery to accelerate R&D to develop new antibiotics and alternatives to antibiotics.More